Loading clinical trials...
Loading clinical trials...
Cardiac allograft vasculopathy (CAV) is a progressive disease of the coronary arteries in transplanted hearts which is a significant cause of morbidity and mortality. The broad objective of this resea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
Collaborators
NCT04770012 · Cardiac Allograft Vasculopathy, Heart Transplant
NCT02798731 · Cardiac Allograft Vasculopathy
NCT05826444 · Cardiac Allograft Vasculopathy
NCT03386539 · Pediatric Heart Transplantation, Immunosuppression, and more
NCT05756088 · Cardiac Allograft Vasculopathy, Endothelial Dysfunction, and more
Mayo Clinic
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions